tiprankstipranks
Trending News
More News >
LAVA Therapeutics (LVTX)
NASDAQ:LVTX
US Market

LAVA Therapeutics (LVTX) Income Statement

Compare
164 Followers

LAVA Therapeutics Income Statement

Last quarter (Q3 2025), LAVA Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, LAVA Therapeutics's net income was $-7.19M. See LAVA Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 11.98M$ 6.77M$ 19.39M$ 5.35M$ 3.75M
Gross Profit
$ 11.98M$ 3.29M$ 19.39M$ 5.35M$ -11.95M
Operating Expenses
$ 41.67M$ 46.68M$ 54.23M$ 48.96M$ 2.72M
Depreciation and Amortization
$ 467.00K$ 612.00K$ 781.00K$ 558.00K$ 213.00K
EBITDA
$ -23.50M$ -40.53M$ -30.80M$ -41.02M$ -14.46M
Operating Income
$ -29.69M$ -43.39M$ -34.84M$ -43.61M$ -14.67M
Other Income/Expenses
$ 5.21M$ 1.78M$ 3.18M$ 1.42M$ -1.21M
Pretax Income
$ -24.48M$ -41.61M$ -31.66M$ -42.20M$ -15.88M
Net Income
$ -25.11M$ -41.87M$ -31.91M$ -42.35M$ -15.93M
Per Share Metrics
Basic EPS
$ -0.94$ -1.57$ -1.23$ -2.14$ -39.90
Diluted EPS
$ -0.94$ -1.57$ -1.23$ -2.14$ -39.90
Weighted Average Shares Outstanding
26.83M 26.73M 25.92M 19.76M 25.35M
Weighted Average Shares Outstanding (Diluted)
26.83M 26.73M 25.92M 19.76M 25.35M
Currency in USD

LAVA Therapeutics Earnings and Revenue History